Reducing CDK4/6-p16(INK4a) interface. Computational alanine scanning of a peptide bound to CDK6 protein
Oscar Villacañas1, Jaime Rubio-Martinez
1Departament de Química Física, Universitat de Barcelona, Martí i Franquès 1, E-08028 Barcelona, Spain.
Abstract:
The tumor suppressor gene p16INK4a is commonly found altered in numerous and different types of cancer. The encoded protein arrests cell cycle in G1 phase by binding to CDK4 and CDK6, inhibiting their kinase function. In 1995, a 20-residue peptide, extracted from p16INK4a protein sequence, was discovered that retains the cell cycle inhibition properties of the endogenous tumor suppressor. However, its structure has not been determined yet. In this article, the features of a theoretical structure of the peptide bound to CDK6 are reported. The complex was modeled from CDK6-p16INK4a X-ray crystal structure and through molecular dynamics. Final structure was assessed by comparing computed binding free energy changes, when single-alanine substitutions were brought about on the peptide, to experimental data. Better concordance was obtained when including a high level of solvation effects. Solute-solvent vdW energy and electrostatic energy between solute and first shells of water, computed through a force field and considering explicit waters, were also to be included to achieve reasonably good concordance between theoretical and experimental data.
Insights
Researchers modeled the theoretical structure of a p16INK4a peptide bound to CDK6, a protein involved in cell cycle arrest. This structure, refined with solvation effects, aids understanding of cancer suppressor mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The p16INK4a tumor suppressor gene is frequently altered in various cancers.
- Its encoded protein inhibits cell cycle progression by binding to CDK4 and CDK6.
- A p16INK4a-derived peptide retains cell cycle inhibition but lacks a determined structure.
Purpose of the Study:
- To report the features of a theoretical structure of the p16INK4a peptide bound to CDK6.
- To provide insights into the molecular mechanisms of cell cycle inhibition by the peptide.
Main Methods:
- Modeling of the p16INK4a peptide-CDK6 complex using X-ray crystallography data.
- Molecular dynamics simulations to refine the complex structure.
- Assessment of the theoretical structure by comparing computed binding free energy changes with experimental data from single-alanine substitutions.
Main Results:
- A theoretical structure of the p16INK4a peptide bound to CDK6 was successfully modeled.
- Inclusion of high-level solvation effects, including solute-solvent van der Waals and electrostatic energies, significantly improved concordance between computed and experimental data.
- The study highlights the importance of solvation in accurately predicting protein-peptide interactions.
Conclusions:
- The reported theoretical structure provides a basis for understanding the interaction between the p16INK4a peptide and CDK6.
- Accurate structural modeling of such complexes requires careful consideration of solvation effects.
- This work contributes to the development of strategies targeting cell cycle regulation in cancer therapy.
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex
DNA Damage can Stall the Cell Cycle


